BioPharma Dive May 8, 2024
The drugmaker is pulling the shot from all markets, ending a turbulent saga that saw it successfully develop a coronavirus shot but struggle to sell it.
Dive Brief:
- AstraZeneca will no longer manufacture or supply its COVID-19 vaccine Vaxzevria, announcing Tuesday it is voluntarily withdrawing the shot due to a “decline in demand,” a spokesperson wrote in an email to BioPharma Dive.
- Prior to the announcement, the company had already taken steps to pull Vaxzevria from the market in Europe. It submitted a withdrawal request there in March which took effect on May 7.
- The decision to withdraw the vaccine comes just after the company reported plummeting yearly sales for Vaxzevria, and reportedly admitted in court documents...
Today's Sponsors
Today's Sponsor